Share This Article:

Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma

Full-Text HTML XML Download Download as PDF (Size:2412KB) PP. 157-168
DOI: 10.4236/crcm.2015.45033    2,063 Downloads   2,488 Views   Citations

ABSTRACT

Sarcomas are relatively rare malignancies; however, their huge variety and shortage of the effective therapies make this disease face huge challenge for oncology. It is recently shown that hyperthermia could be successfully applied even in high-risk cases in combination with the available gold-standard regiments. Our aim is to present various advanced cases treated with a new hyperthermia method, oncothermia, showing its advantages and feasibility to successfully treat highly advanced sarcomas with curative intent.

Cite this paper

Jeung, T. , Ma, S. , Choi, J. , Yu, J. , Lee, S. and Lim, S. (2015) Results of Oncothermia Combined with Operation, Chemotherapy and Radiation Therapy for Primary, Recurrent and Metastatic Sarcoma. Case Reports in Clinical Medicine, 4, 157-168. doi: 10.4236/crcm.2015.45033.

References

[1] Surveillance, Epidemiology, and End Results (SEER) Research Data, Nov 2010 Sub (1973-2008) Total U.S., 1969-2009. National Cancer Institute, Surveillance Research Program, Cancer Statistics Branch, Released April 2011, Based on the November 2010 Submission.
http://seer.cancer.gov/
[2] Fletcher, C.D.M., Krishnan, U.K. and Mertens, F. (2002) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IRAC Press, Lyon, 298.
[3] Lahat, G., Lazar, A. and Lev, D. (2008) Sarcoma Epidemiology and Etiology: Potential Environmental and Genetic Factors. Surgical Clinics, 88, 451-481.
http://dx.doi.org/10.1016/j.suc.2008.03.006
[4] Cheong, D., Gonzalez, R.J. and Zager, J.S. (2011) Strategies for Solutions in Sarcoma Management. Cancer Control, 18, 148-149.
[5] Riddle. N.D., Gonzalez, R.J., Bridge, J.A., Antonia, S. and Bui, M.M. (2011) A CD117 and CD34 Immunoreactive Sarcoma Masquerading as a Gastrointestinal Stromal Tumor: Diagnostic Pitfalls of Ancillary Studies of Sarcoma. Cancer Control, 18, 152-159.
[6] D’Angelo, S.P., Tap, W.D., Schwartz, G.K. and Carvajal, R.D. (2014) Sarcoma Immunotherapy: Past Approaches and Future Directions. Sarcoma, 2014, Article ID: 391967.
http://dx.doi.org/10.1155/2014/391967
[7] Reed, D. and Altiok, S. (2011) Metastatic Soft Tissue Sarcoma Cemeotherapy: An Opportunity for Personalized Medicine. Cancer Control, 18, 188-195.
[8] National Cancer Institute (2010) Snapshots of Specific Types of Cancer. National Cancer Institute.
http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/snapshots
[9] Amankwah, E.K., Conley, A.P. and Reed, D.R. (2013) Epidemiology and Therapies for Metastatic Sarcoma. Clinical Epidemiology, 5, 147-162.
[10] Hohenberger, P. and Wysocki, W.M. (2008) Neoadjuvant Treatment of Locally Advanced Soft Tissue Sarcoma of the Limbs: Which Treatment to Choose? The Oncologist, 13, 175-186.
http://dx.doi.org/10.1634/theoncologist.2007-0165
[11] Amankwah, E.K., Conley, A.P. and Reed, D.R. (2013) Epidemiology and Therapies for Metastatic Sarcoma. Clinical Epidemiology, 5, 147-162.
[12] Banerjee, R., Bandopadhyay, D. and Abilash, V.G. (2013) Epidemiology, Pathology, Types and Diagnosis of Soft Tissue Sarcoma: A Research Review. Asian Journal of Pharmaceutical and Clinical Research, 6, 18-25.
[13] Marulanda, G.A., Henderson, E.R., Johnson, D.A., Letson, G.D. and Cheong, D. (2008) Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma. Cancer Control, 15, 13-20.
[14] Marulanda, G.A. and Letson, G.D. (2014) Controversies in Sarcoma.
http://sarcomahelp.org/articles/controversies.html
[15] Esler, C.P. and Ashford, R.U. (2013) Radiotherapy Controversies in the Radical Treatment of Soft-Tissue Sarcomas of the Limb. European Oncology & Haematology, 9, 42-45.
[16] Fiegl, M., Schlemmer, M., Wndtner, C.M., Abdel-Rahman, S., Fahn, W. and Issels, R.D. (2004) Isofamide, Carboplatin and Etoposide (ICE) as Second-Line Regimen Alone and in Combination with Regional Hyperthermia Is Active in Chemo-Pre-Treated Advanced Soft Tissue Sarcoma of Adults. International Journal of Hyperthermia, 20, 661-670.
http://dx.doi.org/10.1080/02656730410001714959
[17] Doi, O., Kodama, K., Tatsuta, M., Higashiyama, M., Aoki, Y., Kuriyama, K., et al. (1990) Effectiveness of Intrathoracic Chemothermotherapy for Malignant Pleurisy Due to Ewing’s Sarcoma: A Case Report. International Journal of Hyperthermia, 6, 963-969.
http://dx.doi.org/10.3109/02656739009140979
[18] Hiraoka, M., Nishimura, Y., Nagata, Y., Mitsumori, M., Okuno, Y., Li, P.Y., et al. (1995) Clinical Results of Thermoradiotherapy for Soft Tissue Tumors. International Journal of Hyperthermia, 11, 365-377.
http://dx.doi.org/10.3109/02656739509022472
[19] Egawa, S., Tsukiyama, I., Kajiura, Y., et al. (1993) Clinical Results of Hyperthermia Combined with Radiation or Chemotherapy for Soft-Tissue Sarcomas. In: Matsuda, T., Ed., Cancer Treatment by Hyperthermia, Radiation and Drugs, Taylor and Francis, London, 290-299.
[20] Otsuka, T., Yonezawa, M., Kamiyama, F., Matsushita, Y. and Matsui, N. (2001) Results of Surgery and Radio-Hyper-Thermo-Chemotherapy for Patients with Soft-Tissue Sarcoma. International Journal of Clinical Oncology, 6, 253-258.
http://dx.doi.org/10.1007/PL00012114
[21] Leopold, K. and Issels, R.D. (2012) Thermoradiotherapy and Thermochemotherapy for Sarcomas. In: Seegenschmiedt, M.H., Fessenden, P. and Vernon, C.C., Eds., Thermo-Radiotherapy and Thermo-Chemotherapy, Vol. 2, Clinical Applications, Springer, Berlin, 147-158.
[22] Prosnitz, L.R., Maguire, P., Anderson, J.M., Scully, S.P., Harrelson, J.M., Jones, E.L., et al. (1999) The Treatment of High-Grade Soft Tissue Sarcomas with Preoperative Thermoradiotherapy. International Journal of Radiation Oncology*Biology*Physics, 45, 941-949.
http://dx.doi.org/10.1016/S0360-3016(99)00272-2
[23] Issels, R.D., Bosse, D., Abdel-Rahman, S., Starck, M., Panzer, M., Jauch, K.W., et al. (1993) Preoperative Systemic Etioposide/Ifosfamide/Dox-Orubicin Chemotherapy Combined with Regional Hyperthermia in High-Risk Sarcoma: A Pilot Study. Cancer Chemotherapy and Pharmacology, 31, S233-S237.
[24] Issels, R.D., Abdel-Rahman, S., Wendtner, C.M., Falk, M.H., Kurze, V., Sauer, H., et al. (2001) Neoadjuvant Chemotherapy Combined with Regional Hyperhtermia (RHT) for Locally Advanced Primary or Recurrent High-Risk Adult Soft-Tissue Sarcomas (STS) of Adults: Long-Term Results of a Phase II Study. European Journal of Cancer, 37, 1599-1608.
http://dx.doi.org/10.1016/S0959-8049(01)00183-6
[25] Schraffordt, K.H., Eggermont, A.M., Lienard, D., Kroon, B.B.R., Hoekstra, H.J., et al. (1998) Hyperthermic Isolated Limb Perfusion for the Treatment of Soft Tissue Sarcomas. Seminars in Surgical Oncology, 14, 210-214.
http://dx.doi.org/10.1002/(SICI)1098-2388(199804/05)14:3<210::AID-SSU4>3.0.CO;2-B
[26] Kim, C.J., Puleo, C., Letson, G.D. and Reintgen, D. (2001) Hyperthermic Isolated Limb Perfusion for Extremity Sarcomas. Cancer Control: Journal of the Moffitt Cancer Center, 8, 269-273.
[27] Issels, R.D., Lindner, L.H., Verweij, J., Wust, P., Reichardt, P., Schem, B.-C., et al. (2010) Neo-Adjuvant Chemotherapy Alone or with Regional Hyperthermia for Localised High-Risk Soft-Tissue Sarcoma: A Randomised Phase 3 Multicentre Study. The Lancet Oncology, 11, 561-570.
http://dx.doi.org/10.1016/S1470-2045(10)70071-1
[28] Wiedemann, G.J., Robins, H.I., Katschinski, D.M., Mentzel, M., D’Oleire, F., Kutz, M., et al. (1997) Systemic Hyperthermia and ICE Chemotherapy for Sarcoma Patients: Rationale and Clinical Status. Anticancer Research, 17, 2899-2902.
[29] Wiedemann, G.J., d’Oleire, F., Knop, E., Eleftheriadis, S., Bucsky, P., Feddersen, S., et al. (1994) Ifosfamide and Carboplatin Combined with 41.8 Degrees C Whole-Body Hyperthermia in Patients with Refractory Sarcoma and Malignant Teratoma. Cancer Research, 54, 5346-5350.
[30] Chen, W., Zhu, H., Zhang, L., Li, K.Q., Su, H.B., Jin, C.B., et al. (2010) Primary Bone Malignancy: Effective Treatmentwith High-Intensity Focused Ultrasound Ablation. Radiology, 255, 967-978.
http://dx.doi.org/10.1148/radiol.10090374
[31] Hu, Y.C., Ji, J.T. and Lun, D.X. (2011) Intraoperative Microwave Inactivation In-Situ of Malignant Tumors in the Scapula. Orthopaedic Surgery, 4, 229-235.
http://dx.doi.org/10.1111/j.1757-7861.2011.00149.x
[32] Szasz, A. (2013) “Quo Vadis” Oncologic Hyperthermia? Conference Papers in Medicine, 2013, Article ID: 201671.
[33] Roussakow, S. (2013) The History of Hyperthermia Rise and Decline. Conference Papers in Medicine, 2013, Article ID: 428027.
[34] Baronzio, G., Jackson, M., Lee, D. and Szasz, A. (2013) Editorial of the Conference of the International Clinical Hyperthermia Society 2012. Conference Papers in Medicine, 2013, Article ID: 690739.
[35] Szasz, A., Szasz, N. and Szasz, O. (2010) Oncothermia: Principles and Practices. Springer, Dordrecht, Heidelberg.
[36] Szasz, O. and Szasz, A. (2014) Oncothermia—Nano-Heating Paradigm. Journal of Cancer Science & Therapy, 6, 117-121.
http://omicsonline.org/open-access/oncothermia-nanoheating-paradigm-1948-5956.1000259.pdf
[37] Meggyeshazi, N., Andocs, G., Balogh, L., Balla, P., Kiszner, G., Teleki, I., et al. (2014) DNA Fragmentation and Caspase-Independent Programmed Cell Death by Modulated Electrohyperthermia. Strahlentherapie und Onkologie, 190, 815-822.
http://dx.doi.org/10.1007/s00066-014-0617-1
[38] Andocs, G., Meggyeshazi, N., Balogh, L., Spisak, S., Maros, M.E., Balla, P., et al. (2014) Upregulation of Heat Shock Proteins and the Promotion of Damage-Associated Molecular Pattern Signals in a Colorectal Cancer Model by Modulated Electrohyperthermia. Cell Stress and Chaperones, 20, 37-46.
http://dx.doi.org/10.1007/s12192-014-0523-6
[39] Volovat, S.R., Volovat, C., Scripcariu, V., Lupascu, C. and Miron, L. (2014) The Results of Combination of Ifosfamid and Locoregional Hyperthermia (EHY 2000) in Patients with advanced Abdominal Soft-Tissue Sarcoma after Relapse of First Line Chemotherapy. Romanian Reports in Physics, 66, 175-181.

  
comments powered by Disqus

Copyright © 2017 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.